{"id":48491,"date":"2022-08-25T08:00:20","date_gmt":"2022-08-25T08:00:20","guid":{"rendered":"https:\/\/www.arisglobal.com\/?p=48491"},"modified":"2022-08-25T08:00:20","modified_gmt":"2022-08-25T08:00:20","slug":"arisglobal-heads-to-boston-for-flagship-life-sciences-conference-breakthrough2022","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/media\/press-release\/arisglobal-heads-to-boston-for-flagship-life-sciences-conference-breakthrough2022\/","title":{"rendered":"ArisGlobal Heads to Boston for Flagship Life Sciences Conference, Breakthrough2022"},"content":{"rendered":"

The annual life sciences thought leadership event returns to in person format in Boston on October 3, 2022 ahead of World Drug Safety Congress Americas.<\/span><\/i><\/p>\n

(MIAMI, FL and BOSTON, MA) <\/b>\u2014<\/b> August 25, 2022 <\/b>\u2014<\/b> ArisGlobal<\/span><\/a>, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform, LifeSphere\u00ae, today announced the leading speakers for its upcoming Breakthrough2022 Conference. Attendees will hear insights directly from pharmaceutical and biotech companies that are using a range of technology solutions, such as ArisGlobal\u2019s proprietary LifeSphere platform, to face and conquer challenges in research and development. Talk tracks will cover trends in pharmacovigilance and safety, clinical trial management, and regulatory compliance with a focus on data & analytics, automation and AI, and more.\u00a0\u00a0\u00a0<\/span><\/p>\n

Held as a one-day life sciences thought leadership event in Boston, Breakthrough2022 will take place the day prior to World Drug Safety Congress Americas, making attendance for industry professionals seamless.\u00a0<\/span><\/p>\n

\u201cBreakthrough facilitates a dialogue across many organizations on how we can improve patient outcomes with technology,\u201d shares Karen de Jong, Executive Director Global Case Management, Patient Safety & Pharmacovigilance Boehringer Ingelheim Pharmaceuticals. \u201cI\u2019m excited to see the latest innovative strategies our life sciences colleagues are bringing to the industry.\u201d\u00a0\u00a0\u00a0<\/span><\/p>\n

In addition to speaking sessions by life sciences thought leaders, ArisGlobal\u2019s signature event will feature a variety of on-site experiences, such as an Innovation Center, a networking hub, and partner-sponsored demos. Breakthrough2022 guests will also be among the first to see LifeSphere\u00ae Clarity, an unmatched data and analytics engine acquired<\/span> earlier this year<\/span><\/a> from Boehringer-Ingelheim and further developed by ArisGlobal.\u00a0\u00a0\u00a0<\/span><\/p>\n

\u201cAt ArisGlobal, Breakthrough is an important time of year, where we bring leaders from across pharmaceutical and biotech organizations together to talk about what they are doing, lessons they have learned, and where they see the industry going,\u201d shares Heidi Hattendorf, VP and Head of Marketing for ArisGlobal, \u201cThis year is extra special for us, as we will convene in Boston, a dynamic city and epicenter for biopharma where ArisGlobal has a strong presence.\u201d<\/span><\/p>\n

The agenda is developing further with innovative speakers and thought leaders from a variety of pharmaceutical, digital health, and biotech organizations. To date, confirmed speakers include representatives from:\u00a0<\/span><\/p>\n